Filing Details
- Accession Number:
- 0000950170-25-084587
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-10 20:07:37
- Reporting Period:
- 2025-06-10
- Filing Date:
- 2025-06-10
- Accepted Time:
- 2025-06-10 20:07:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1712601 | B. Steven Binder | 1 Casper Street Danbury CT 06810 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Disposition | 2025-06-10 | 64,085 | $4.00 | 925,258 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction occurred pursuant to Rule 10B5-1 Plan established August 19, 2024.
- The weighted average sales price of the reported transaction was $4.00 based on a range of prices between $3.91 and $4.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.